Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
NCT01196650 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2011-05-03
Summary
This study aims to assess the efficacy of IN 10 003 in improving sleep parameters in patients with Insomnia exhibiting both difficulty in falling asleep and staying asleep. The study will compare 2 formulations of the IN 10 003 to placebo
Conditions
- Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
Interventions
- DRUG
-
IN 10 003 formulation A
- DRUG
-
IN 10 003 formulation B
- DRUG
-
Placebo capsules
Sponsors & Collaborators
-
Intec Pharma Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
Countries
- Israel
Study Locations
More Related Trials
-
Efficacy Study of EVT 201 to Treat Insomnia
NCT00380003 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Chronic Hypnotic Use 2
NCT02456532 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
NCT06680505 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
NCT02852395 ·Status: COMPLETED ·Phase: PHASE1
-
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
NCT00352144 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
NCT01995838 ·Status: COMPLETED ·Phase: PHASE2
-
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
NCT00606593 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs
NCT00683436 ·Status: TERMINATED ·Phase: PHASE2
-
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
NCT00608985 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2624803 in Participants With Transient Insomnia
NCT01779830 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
NCT00551148 ·Status: COMPLETED ·Phase: PHASE2
-
Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers
NCT00716521 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia
NCT03814135 ·Status: WITHDRAWN ·Phase: PHASE2
-
Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
NCT01021852 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
NCT00699608 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity
NCT02464046 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants
NCT04551079 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
NCT05525637 ·Status: RECRUITING ·Phase: PHASE3
-
A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia
NCT00748592 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia
NCT00380081 ·Status: COMPLETED ·Phase: PHASE3
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
NCT00755495 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
NCT01463098 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
NCT06673927 ·Status: COMPLETED ·Phase: PHASE1